Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viral Shedding of CAIV-T in Healthy Children
NCT00192387Phase 2Completed
- Sponsor
- MedImmune
- Start
- Sep 2001
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in influenza comparing CAIV-T with Placebo (2 arms). Primary endpoints: Proportion of subjects who shed each vaccine virus strain and Measurement of influenza-specific immune response. Started Sep 2001; status: completed.
02
Drugs
live attenuated influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00192387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00192387.